Otonomy Inc (OTIC) is expected to report $-0.47 for 4Q.
Party City Holdco Inc (PRTYQ) is expected to report $-0.02 for 4Q.
Pear Therapeutics Inc (PEAR) is expected to report for 4Q.
Pieris Pharmaceuticals Inc (PIRS) is expected to report $-0.21 for 4Q.
Satsuma Pharmaceuticals Inc (STSA) is expected to report for 4Q.
Sigmatron International Inc (SGMA) is expected to report for 3Q.
StarTek Inc (SRT) is expected to report $0.06 for 4Q.
Table Trac Inc (TBTC) is expected to report for 4Q.
Tango Therapeutics Inc (TNGX) is expected to report for 4Q.
Theriva Biologics Inc (TOVX) is expected to report for 4Q.
Thorne Healthtech Inc (THRN) is expected to report for 4Q.
Venus Concept Inc (VERO) is expected to report for 4Q.
Vislink Technologies Inc (VISL) is expected to report for 4Q.
WidePoint Corp (WYY) is expected to report for 4Q.
Powered by Onclusive and Dow Jones.
ANALYST RATINGS ACTIONS
Axonics Raised to Buy From Hold by Needham
Block Cut to Neutral From Overweight by Atlantic Equities
Coinbase Cut to Underperform From Market Perform by TD Cowen
Cracker Barrel Raised to Buy From Hold by Argus Research
Crane Co Cut to Neutral From Buy by UBS
First Horizon Raised to Overweight From Equal-Weight by Wells Fargo
Genuine Parts Raised to Buy From Hold by Truist Securities
Healthcare Services Raised to Hold From Underperform by Jefferies
KB Home Raised to Neutral From Underweight by JP Morgan
Ouster Cut to Neutral From Buy by Chardan Capital
Qualtrics International Cut to Hold From Buy by Truist Securities
Regeneron Pharma Raised to Buy From Hold by Jefferies
Regeneron Pharma Raised to Market Perform From Underperform by Raymond James
Seagen Cut to Hold From Buy by Berenberg
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
03-27-23 0621ET
